Researchers reported that SVR12 rates in real-world, post-transplant genotype 1 HCV patients treated with ledipasvir-sofosbuvir, with or without ribavirin, is 98% across regimens and various characteristics.
Results from the ION-3 trial showed that the rapidity and durability of viral suppression achieved with ledipasvir-sofosbuvir therapy allows a shorter treatment course of 8 weeks in genotype 1, treatment-naïve, non-cirrhotic patients.
With May officially Hepatitis Awareness Month, there is an active campaign underway designed to encourage people to get tested for hepatitis C. May 19 has been designated National Hepatitis Testing Day in the US for the fifth year running.
When a patient is dying, it can be difficult to know what to say to them. Here are a few tips and approaches that I have gathered from experts that I hope will help you get through those hard conversations while continuing to provide the best possible care to your patient.
Being a good doctor is hard work, especially considering the current state of our health care system. Some doctors, however, are simply bad news. And because most doctors today have comparable education and credentials, bad doctors don’t exactly stick out like sore thumbs.